Early High-efficacy DMTs Linked to Better RRMS Outcomes in Sweden

Early High-efficacy DMTs Linked to Better RRMS Outcomes in Sweden

304651

Early High-efficacy DMTs Linked to Better RRMS Outcomes in Sweden

People with relapsing-remitting multiple sclerosis (RRMS) in Sweden have lower rates of worsening disability than those who live in Denmark, likely due to differences in treatment strategies in each country, according to a new study. “This study shows that, for the first time to our knowledge, differences in national treatment recommendations and strategies had a significant association with disability outcomes after a few years of follow-up,” the researchers wrote. The study, “Treatment Escalation vs Immediate…

You must be logged in to read/download the full post.